Novel urinary biomarkers in pre-diabetic nephropathy

Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed pr...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental nephrology Vol. 19; no. 5; pp. 895 - 900
Main Authors Garg, Vikas, Kumar, Manish, Mahapatra, Himansu Sekhar, Chitkara, Anubhuti, Gadpayle, Adesh Kumar, Sekhar, Venketansan
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.10.2015
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1342-1751
1437-7799
1437-7799
DOI10.1007/s10157-015-1085-3

Cover

Loading…
Abstract Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. Methods A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin–creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Results Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL–creatinine ratio (UNCR) and urine Cystatin C–creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 ( p  = 0.000) and 1.138 ( p  = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Conclusion Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.
AbstractList Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. Methods A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin–creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Results Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL–creatinine ratio (UNCR) and urine Cystatin C–creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 ( p  = 0.000) and 1.138 ( p  = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Conclusion Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.
Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. Methods A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Results Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Conclusion Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.BACKGROUNDRenal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.METHODSA total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.RESULTSUrine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.CONCLUSIONTubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.
Author Garg, Vikas
Gadpayle, Adesh Kumar
Chitkara, Anubhuti
Mahapatra, Himansu Sekhar
Kumar, Manish
Sekhar, Venketansan
Author_xml – sequence: 1
  givenname: Vikas
  surname: Garg
  fullname: Garg, Vikas
  organization: Room No 307, Admin Block, PGIMER
– sequence: 2
  givenname: Manish
  surname: Kumar
  fullname: Kumar, Manish
  organization: Room No 307, Admin Block, PGIMER
– sequence: 3
  givenname: Himansu Sekhar
  surname: Mahapatra
  fullname: Mahapatra, Himansu Sekhar
  email: hsmnephro@gmail.com
  organization: Room No 307, Admin Block, PGIMER
– sequence: 4
  givenname: Anubhuti
  surname: Chitkara
  fullname: Chitkara, Anubhuti
  organization: Room No 307, Admin Block, PGIMER
– sequence: 5
  givenname: Adesh Kumar
  surname: Gadpayle
  fullname: Gadpayle, Adesh Kumar
  organization: Room No 307, Admin Block, PGIMER
– sequence: 6
  givenname: Venketansan
  surname: Sekhar
  fullname: Sekhar, Venketansan
  organization: Room No 307, Admin Block, PGIMER
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25634253$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1LxDAQhoMofv8AL1Lw4iWaSTpNehTxC0Qveg7ZNtVoN6lJK-y_N8uqiKCXmUCeJ5l5d8i6D94ScgDsBBiTpwkYoKS5UGAKqVgj21AKSaWs6_V8FiWnIBG2yE5KL4wxVWO9SbY4VvkKxTYp78K77YspOm_iopi5MDfx1cZUOF8M0dLWmZkdXVN4OzzHMJjxebFHNjrTJ7v_2XfJ4-XFw_k1vb2_ujk_u6UNchhpY3hnOdRlVRmBUDJRCYVcNmgVdI2pWStbwaxiNWCLhhkQolMz1SpAgUbskuPVu0MMb5NNo5671Ni-N96GKWmQnJec1xVm9OgX-hKm6PN0SwqUVIgsU4ef1DSb21YP0eV1F_orjwzACmhiSCna7hsBppeZ61XmOhe9zFwvHfnLadxoRhf8GI3r_zX5ykz5F_9k44-h_5Q-AHXmkiU
CODEN CENPFV
CitedBy_id crossref_primary_10_1007_s00125_018_4567_5
crossref_primary_10_3390_chemosensors11060350
crossref_primary_10_1016_j_cca_2018_10_021
crossref_primary_10_11613_BM_2024_020709
crossref_primary_10_3390_ijms22189985
crossref_primary_10_1038_s41598_017_02421_9
crossref_primary_10_1007_s11892_015_0708_0
crossref_primary_10_1016_j_cca_2024_119762
crossref_primary_10_1002_jcla_23487
crossref_primary_10_1007_s13410_020_00911_7
crossref_primary_10_4103_ijmr_IJMR_455_21
crossref_primary_10_1186_s12882_017_0620_8
crossref_primary_10_4103_ijn_IJN_67_20
crossref_primary_10_11613_BM_2019_010501
crossref_primary_10_1373_jalm_2018_028530
crossref_primary_10_51620_0869_2084_2021_66_10_593_602
crossref_primary_10_2147_DMSO_S247062
crossref_primary_10_1155_2016_4647685
crossref_primary_10_1053_j_ackd_2017_10_012
crossref_primary_10_1159_000505155
crossref_primary_10_1016_j_sintl_2023_100253
crossref_primary_10_1155_2016_4626125
crossref_primary_10_1097_XCE_0000000000000180
crossref_primary_10_1186_s40364_015_0042_3
crossref_primary_10_1111_dom_15518
crossref_primary_10_1210_jendso_bvae014
crossref_primary_10_1007_s12010_018_2919_8
crossref_primary_10_1159_000507858
crossref_primary_10_1186_s12896_018_0449_7
crossref_primary_10_2147_DMSO_S392888
crossref_primary_10_3390_ijms23158668
crossref_primary_10_5812_jjcdc_142750
crossref_primary_10_1002_ar_24835
crossref_primary_10_1016_j_dsx_2021_05_025
crossref_primary_10_1016_j_jcjd_2021_07_004
crossref_primary_10_3390_jcm9103289
crossref_primary_10_3389_fcell_2021_630401
crossref_primary_10_3389_fphar_2021_680336
crossref_primary_10_1016_j_bbapap_2020_140475
crossref_primary_10_1007_s13410_015_0461_6
crossref_primary_10_1007_s10544_020_00484_6
crossref_primary_10_1080_10408363_2017_1377682
crossref_primary_10_1016_j_dsx_2018_04_017
Cites_doi 10.1503/cmaj.061590
10.1053/ajkd.2002.34487
10.7326/0003-4819-130-6-199903160-00002
10.1152/ajprenal.00142.2008
10.1056/NEJMoa0806470
10.1681/ASN.2006040368
10.1159/000078452
10.2337/dc09-1098
10.3346/jkms.2011.26.2.258
10.2337/dc14-S081
10.1681/ASN.2005121324
10.1111/j.1752-8062.2008.00053.x
10.1016/j.clinbiochem.2004.09.025
10.1152/ajpendo.00299.2007
10.1016/S0140-6736(99)12323-7
10.2337/dc13-0985
10.1001/jama.289.24.3273
10.2337/dc10-1545
10.1053/j.ajkd.2012.07.005
10.1016/j.diabres.2011.09.031
10.1053/j.ackd.2005.01.008
10.1007/s12020-011-9509-7
10.1016/j.bbrc.2007.04.072
10.1515/CCLM.2006.050
10.1097/01.ASN.0000088027.54400.C6
10.1016/j.clinbiochem.2013.05.072
10.1172/JCI23056
10.1111/j.1464-5491.2010.03083.x
10.1016/S0272-6386(04)01079-0
10.1007/s00592-013-0485-7
10.1152/ajprenal.00008.2003
10.2337/diab.37.5.532
10.4093/dmj.2012.36.4.307
10.2337/dc12-0849
10.1016/S0140-6736(05)74811-X
10.3892/etm.2013.1315
ContentType Journal Article
Copyright Japanese Society of Nephrology 2015
Copyright_xml – notice: Japanese Society of Nephrology 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s10157-015-1085-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1437-7799
EndPage 900
ExternalDocumentID 3835158511
25634253
10_1007_s10157_015_1085_3
Genre Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
203
29B
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
PZZ
Q2X
QOR
QOS
R89
R9I
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
Z7U
Z81
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c521t-ca2fe219466a351403638527c5e81fca90d7d30e80915d5a0a133f8b8d81535a3
IEDL.DBID U2A
ISSN 1342-1751
1437-7799
IngestDate Tue Aug 05 10:00:25 EDT 2025
Sat Aug 16 07:51:09 EDT 2025
Mon Jul 21 06:05:01 EDT 2025
Tue Jul 01 03:35:48 EDT 2025
Thu Apr 24 23:04:10 EDT 2025
Fri Feb 21 02:33:27 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords NGAL
Diabetic nephropathy
Pre-diabetes
Cystatin C
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c521t-ca2fe219466a351403638527c5e81fca90d7d30e80915d5a0a133f8b8d81535a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25634253
PQID 1721878550
PQPubID 43386
PageCount 6
ParticipantIDs proquest_miscellaneous_1722422965
proquest_journals_1721878550
pubmed_primary_25634253
crossref_primary_10_1007_s10157_015_1085_3
crossref_citationtrail_10_1007_s10157_015_1085_3
springer_journals_10_1007_s10157_015_1085_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationSubtitle Official Publication of the Japanese Society of Nephrology
PublicationTitle Clinical and experimental nephrology
PublicationTitleAbbrev Clin Exp Nephrol
PublicationTitleAlternate Clin Exp Nephrol
PublicationYear 2015
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Mishra, Ma, Prada, Mitsnefes (CR14) 2003; 14
Makris, Nikolaki, Nanopoulos, Pirqakis (CR29) 2013; 46
Kramer, Nguyen, Curhan, Hsu (CR6) 2003; 289
Jeon, Kim, Huh, Mok (CR9) 2011; 26
Russo, Sandoval, Campos (CR38) 2006; 17
Mishra, Mori, Ma, Kelly, Barasch, Devarajan (CR15) 2004; 24
Tapp, Shaw, Zimmet, Balkau (CR26) 2004; 44
Fu, Xiong, Fang, Wen (CR34) 2012; 41
Duncan, Walker, Ezzat, Wheatcroft (CR28) 2007; 293
Thomas, Burns, Cooper (CR2) 2005; 12
Mori, Lee, Rapoport, Drexler (CR35) 2005; 115
Kim, Song, Kim, Jeon (CR17) 2013; 36
Fu, Li, Wang, Chen (CR20) 2012; 95
Yang, Mori, Li, Barasch (CR13) 2003; 285
Remuzzi, Macia, Ruggenenti (CR22) 2006; 17
Comper, Hilliard, Nikolic-Paterson, Russo (CR3) 2008; 295
Tarsio, Reger, Furcht (CR27) 1988; 37
Assal, Tawfeek, Rasheed, Lebedy (CR33) 2013; 6
Krolewski, Niewczas, Skupien (CR4) 2014; 37
Molitch, Steffes, Sun (CR5) 2010; 33
(CR7) 2012; 60
Wu, Ding, Zhu, Shao (CR19) 2013; 6
Woo, Choi, Kim, Kim (CR31) 2012; 36
Dharnidharka, Kwon, Stevens (CR11) 2002; 40
Nauta, Boertien, Bakker, Goor (CR18) 2011; 34
Filler, Bokenkamp, Hofmann, Le Bricon (CR12) 2005; 38
Levey, Bosch, Lewis, Green (CR25) 1999; 130
(CR23) 2000; 355
Nielsen, Schjoedt, Astrup, Tarnow (CR10) 2010; 27
Kaseda, Iino, Hosojima, Takeda (CR36) 2007; 357
Holman, Paul, Bethel, Matthews (CR21) 2008; 359
CR24
(CR1) 2014; 37
Barratt, Topham (CR8) 2007; 177
Conti, Moutereau, Zater, Lallali (CR30) 2006; 44
Mishra, Dent, Tarabishi, Mitsnefes (CR16) 2005; 365
Vaidya, Waikar, Ferguson (CR37) 2008; 1
Lacquaniti, Donato, Pintaudi, Vieste (CR32) 2013; 50
WD Comper (1085_CR3) 2008; 295
J Barratt (1085_CR8) 2007; 177
WJ Fu (1085_CR34) 2012; 41
HJ Kramer (1085_CR6) 2003; 289
J Yang (1085_CR13) 2003; 285
WJ Fu (1085_CR20) 2012; 95
J Mishra (1085_CR14) 2003; 14
FL Nauta (1085_CR18) 2011; 34
1085_CR24
KS Woo (1085_CR31) 2012; 36
J Mishra (1085_CR16) 2005; 365
SE Nielsen (1085_CR10) 2010; 27
RR Holman (1085_CR21) 2008; 359
RJ Tapp (1085_CR26) 2004; 44
National Kidney Foundation (1085_CR7) 2012; 60
M Conti (1085_CR30) 2006; 44
AS Levey (1085_CR25) 1999; 130
K Mori (1085_CR35) 2005; 115
G Filler (1085_CR12) 2005; 38
J Wu (1085_CR19) 2013; 6
LM Russo (1085_CR38) 2006; 17
Heart Outcomes Prevention Evaluation Study Investigators (1085_CR23) 2000; 355
K Makris (1085_CR29) 2013; 46
R Kaseda (1085_CR36) 2007; 357
ME Molitch (1085_CR5) 2010; 33
J Mishra (1085_CR15) 2004; 24
AS Krolewski (1085_CR4) 2014; 37
SS Kim (1085_CR17) 2013; 36
VS Vaidya (1085_CR37) 2008; 1
JF Tarsio (1085_CR27) 1988; 37
YK Jeon (1085_CR9) 2011; 26
MC Thomas (1085_CR2) 2005; 12
American Diabetes Association (1085_CR1) 2014; 37
ER Duncan (1085_CR28) 2007; 293
A Lacquaniti (1085_CR32) 2013; 50
VR Dharnidharka (1085_CR11) 2002; 40
G Remuzzi (1085_CR22) 2006; 17
HS Assal (1085_CR33) 2013; 6
22950063 - Diabetes Metab J. 2012 Aug;36(4):307-13
21779943 - Endocrine. 2012 Feb;41(1):82-8
19118149 - J Am Soc Nephrol. 2009 Mar;20(3):489-94
21286018 - J Korean Med Sci. 2011 Feb;26(2):258-63
15607309 - Clin Biochem. 2005 Jan;38(1):1-8
17698825 - CMAJ. 2007 Aug 14;177(4):361-8
15822053 - Adv Chronic Kidney Dis. 2005 Apr;12(2):177-86
15711640 - J Clin Invest. 2005 Mar;115(3):610-21
22015481 - Diabetes Res Clin Pract. 2012 Jan;95(1):105-9
20413518 - Diabetes Care. 2010 Jul;33(7):1536-43
10075613 - Ann Intern Med. 1999 Mar 16;130(6):461-70
15492944 - Am J Kidney Dis. 2004 Nov;44(5):792-8
23067652 - Am J Kidney Dis. 2012 Nov;60(5):850-86
23754672 - Acta Diabetol. 2013 Dec;50(6):935-42
17711985 - Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1311-9
21307379 - Diabetes Care. 2011 Apr;34(4):975-81
14514731 - J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43
10675071 - Lancet. 2000 Jan 22;355(9200):253-9
16565256 - J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7
16519600 - Clin Chem Lab Med. 2006;44(3):288-91
17462596 - Biochem Biophys Res Commun. 2007 Jun 15;357(4):1130-4
18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89
23966807 - Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13
12824208 - JAMA. 2003 Jun 25;289(24):3273-7
23093662 - Diabetes Care. 2013 Mar;36(3):656-61
3360214 - Diabetes. 1988 May;37(5):532-9
24250725 - Exp Ther Med. 2013 Dec;6(6):1482-1488
20854382 - Diabet Med. 2010 Oct;27(10 ):1144-50
12788784 - Am J Physiol Renal Physiol. 2003 Jul;285(1):F9-18
24357215 - Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
18579704 - Am J Physiol Renal Physiol. 2008 Dec;295(6):F1589-600
23770456 - Clin Biochem. 2013 Aug;46(12):1128-30
19212447 - Clin Transl Sci. 2008 Dec;1(3):200-8
15811456 - Lancet. 2005 Apr 2-8;365(9466):1231-8
23939543 - Diabetes Care. 2014;37(1):226-34
12148093 - Am J Kidney Dis. 2002 Aug;40(2):221-6
15148457 - Am J Nephrol. 2004 May-Jun;24(3):307-15
References_xml – volume: 177
  start-page: 361
  year: 2007
  end-page: 368
  ident: CR8
  article-title: Urine proteomics: the present and future of measuring urinary protein components in disease
  publication-title: CMAJ.
  doi: 10.1503/cmaj.061590
– volume: 40
  start-page: 221
  year: 2002
  end-page: 226
  ident: CR11
  article-title: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
  publication-title: Am J Kidney Dis.
  doi: 10.1053/ajkd.2002.34487
– volume: 130
  start-page: 461
  year: 1999
  end-page: 470
  ident: CR25
  article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group
  publication-title: Ann Intern Med.
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 295
  start-page: F1589
  year: 2008
  end-page: F1600
  ident: CR3
  article-title: Disease dependent mechanism of albuminuria
  publication-title: Am J Physiol Renal Physiol.
  doi: 10.1152/ajprenal.00142.2008
– volume: 359
  start-page: 1577
  year: 2008
  end-page: 1589
  ident: CR21
  article-title: 10-year follow-up of intensive glucose control in type 2 diabetes
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa0806470
– volume: 17
  start-page: 2937
  year: 2006
  end-page: 2944
  ident: CR38
  article-title: Impaired tubular uptake explains albuminuria in early diabetic nephropathy
  publication-title: J Am Soc Nephrol.
  doi: 10.1681/ASN.2006040368
– volume: 24
  start-page: 307
  year: 2004
  end-page: 315
  ident: CR15
  article-title: Neutrophil gelatinase associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity
  publication-title: Am J Nephrol.
  doi: 10.1159/000078452
– volume: 33
  start-page: 1536
  year: 2010
  end-page: 1543
  ident: CR5
  article-title: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study
  publication-title: Diabetes Care.
  doi: 10.2337/dc09-1098
– volume: 26
  start-page: 258
  year: 2011
  end-page: 263
  ident: CR9
  article-title: Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes
  publication-title: J Korean Med Sci.
  doi: 10.3346/jkms.2011.26.2.258
– volume: 37
  start-page: s81
  year: 2014
  end-page: s90
  ident: CR1
  article-title: Diagnosis and classification of diabetes mellitus
  publication-title: Diabetes Care.
  doi: 10.2337/dc14-S081
– volume: 17
  start-page: S90
  issue: S2
  year: 2006
  end-page: S97
  ident: CR22
  article-title: Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study
  publication-title: J Am Soc Nephrol.
  doi: 10.1681/ASN.2005121324
– volume: 1
  start-page: 200
  issue: 3
  year: 2008
  end-page: 208
  ident: CR37
  article-title: Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
  publication-title: Clin Transl Sci.
  doi: 10.1111/j.1752-8062.2008.00053.x
– volume: 38
  start-page: 1
  year: 2005
  end-page: 8
  ident: CR12
  article-title: Cystatin C as a marker of GFR -history, indications, and future research
  publication-title: Clin Biochem.
  doi: 10.1016/j.clinbiochem.2004.09.025
– volume: 293
  start-page: E1311
  year: 2007
  end-page: E1319
  ident: CR28
  article-title: Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species
  publication-title: Am J Physiol Endocrinol Metab.
  doi: 10.1152/ajpendo.00299.2007
– volume: 355
  start-page: 253
  year: 2000
  end-page: 259
  ident: CR23
  article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(99)12323-7
– volume: 37
  start-page: 226
  year: 2014
  end-page: 234
  ident: CR4
  article-title: Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria
  publication-title: Diabetes Care.
  doi: 10.2337/dc13-0985
– volume: 289
  start-page: 3273
  year: 2003
  end-page: 3277
  ident: CR6
  article-title: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus
  publication-title: JAMA.
  doi: 10.1001/jama.289.24.3273
– volume: 34
  start-page: 975
  year: 2011
  end-page: 981
  ident: CR18
  article-title: Glomerular markers are elevated in patients with diabetes
  publication-title: Diabetes Care.
  doi: 10.2337/dc10-1545
– volume: 60
  start-page: 850
  year: 2012
  end-page: 886
  ident: CR7
  article-title: KDOQI clinical practice guideline for diabetes and CKD: 2012 update
  publication-title: Am J Kidney Dis.
  doi: 10.1053/j.ajkd.2012.07.005
– volume: 95
  start-page: 105
  issue: 1
  year: 2012
  end-page: 109
  ident: CR20
  article-title: Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration
  publication-title: Diabetes Res Clin Pract.
  doi: 10.1016/j.diabres.2011.09.031
– volume: 12
  start-page: 177
  year: 2005
  end-page: 186
  ident: CR2
  article-title: Tubular changes in early diabetic nephropathy
  publication-title: Adv Chronic Kidney Dis.
  doi: 10.1053/j.ackd.2005.01.008
– volume: 41
  start-page: 82
  issue: 1
  year: 2012
  end-page: 88
  ident: CR34
  article-title: Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study
  publication-title: Endocrine.
  doi: 10.1007/s12020-011-9509-7
– volume: 357
  start-page: 1130
  issue: 4
  year: 2007
  end-page: 1134
  ident: CR36
  article-title: Megalin-mediated endocytosis of cystatin C in proximal tubule cells
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1016/j.bbrc.2007.04.072
– volume: 44
  start-page: 288
  issue: 3
  year: 2006
  end-page: 291
  ident: CR30
  article-title: Urinary Cystatin C as a specific marker of tubular dysfunction
  publication-title: Clin Chem Lab Med.
  doi: 10.1515/CCLM.2006.050
– volume: 6
  start-page: 1482
  year: 2013
  end-page: 1488
  ident: CR19
  article-title: Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes
  publication-title: Exp Ther Med.
– volume: 14
  start-page: 2534
  year: 2003
  end-page: 2543
  ident: CR14
  article-title: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury
  publication-title: J Am Soc Nephrol.
  doi: 10.1097/01.ASN.0000088027.54400.C6
– volume: 46
  start-page: 1128
  issue: 12
  year: 2013
  end-page: 1130
  ident: CR29
  article-title: Measurement of Cystatin C in human urine by particle enhanced turbidimetric immunoassay on automated biochemistry analyzer
  publication-title: Clin Biochem.
  doi: 10.1016/j.clinbiochem.2013.05.072
– volume: 115
  start-page: 610
  issue: 3
  year: 2005
  end-page: 621
  ident: CR35
  article-title: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury
  publication-title: J Clin Invest.
  doi: 10.1172/JCI23056
– volume: 27
  start-page: 1144
  issue: 10
  year: 2010
  end-page: 1150
  ident: CR10
  article-title: Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril
  publication-title: Diabet Med.
  doi: 10.1111/j.1464-5491.2010.03083.x
– volume: 6
  start-page: 7
  year: 2013
  end-page: 13
  ident: CR33
  article-title: Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus
  publication-title: Clin Med Insights Endocrinol Diab.
– volume: 44
  start-page: 792
  issue: 5
  year: 2004
  end-page: 798
  ident: CR26
  article-title: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
  publication-title: Am J Kidney Dis.
  doi: 10.1016/S0272-6386(04)01079-0
– volume: 50
  start-page: 935
  year: 2013
  end-page: 942
  ident: CR32
  article-title: ‘‘Normoalbuminuric’’ diabetic nephropathy: tubular damage and NGAL
  publication-title: Acta Diabetol.
  doi: 10.1007/s00592-013-0485-7
– volume: 285
  start-page: F9
  year: 2003
  end-page: F18
  ident: CR13
  article-title: Iron, lipocalin, and kidney epithelia
  publication-title: Am J Physiol Renal Physiol.
  doi: 10.1152/ajprenal.00008.2003
– volume: 37
  start-page: 532
  issue: 5
  year: 1988
  end-page: 539
  ident: CR27
  article-title: Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association
  publication-title: Diabetes.
  doi: 10.2337/diab.37.5.532
– volume: 36
  start-page: 307
  year: 2012
  end-page: 313
  ident: CR31
  article-title: Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease
  publication-title: Diabetes Metab J.
  doi: 10.4093/dmj.2012.36.4.307
– volume: 36
  start-page: 656
  year: 2013
  end-page: 661
  ident: CR17
  article-title: Urinary Cystatin C and Tubular proteinuria predict progression of diabetic nephropathy
  publication-title: Diabetes Care.
  doi: 10.2337/dc12-0849
– ident: CR24
– volume: 365
  start-page: 1231
  year: 2005
  end-page: 1238
  ident: CR16
  article-title: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(05)74811-X
– volume: 37
  start-page: s81
  year: 2014
  ident: 1085_CR1
  publication-title: Diabetes Care.
  doi: 10.2337/dc14-S081
– volume: 24
  start-page: 307
  year: 2004
  ident: 1085_CR15
  publication-title: Am J Nephrol.
  doi: 10.1159/000078452
– volume: 95
  start-page: 105
  issue: 1
  year: 2012
  ident: 1085_CR20
  publication-title: Diabetes Res Clin Pract.
  doi: 10.1016/j.diabres.2011.09.031
– volume: 14
  start-page: 2534
  year: 2003
  ident: 1085_CR14
  publication-title: J Am Soc Nephrol.
  doi: 10.1097/01.ASN.0000088027.54400.C6
– volume: 6
  start-page: 7
  year: 2013
  ident: 1085_CR33
  publication-title: Clin Med Insights Endocrinol Diab.
– volume: 44
  start-page: 792
  issue: 5
  year: 2004
  ident: 1085_CR26
  publication-title: Am J Kidney Dis.
  doi: 10.1016/S0272-6386(04)01079-0
– volume: 36
  start-page: 307
  year: 2012
  ident: 1085_CR31
  publication-title: Diabetes Metab J.
  doi: 10.4093/dmj.2012.36.4.307
– volume: 365
  start-page: 1231
  year: 2005
  ident: 1085_CR16
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(05)74811-X
– volume: 46
  start-page: 1128
  issue: 12
  year: 2013
  ident: 1085_CR29
  publication-title: Clin Biochem.
  doi: 10.1016/j.clinbiochem.2013.05.072
– volume: 60
  start-page: 850
  year: 2012
  ident: 1085_CR7
  publication-title: Am J Kidney Dis.
  doi: 10.1053/j.ajkd.2012.07.005
– volume: 6
  start-page: 1482
  year: 2013
  ident: 1085_CR19
  publication-title: Exp Ther Med.
  doi: 10.3892/etm.2013.1315
– volume: 359
  start-page: 1577
  year: 2008
  ident: 1085_CR21
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa0806470
– volume: 17
  start-page: S90
  issue: S2
  year: 2006
  ident: 1085_CR22
  publication-title: J Am Soc Nephrol.
  doi: 10.1681/ASN.2005121324
– volume: 1
  start-page: 200
  issue: 3
  year: 2008
  ident: 1085_CR37
  publication-title: Clin Transl Sci.
  doi: 10.1111/j.1752-8062.2008.00053.x
– volume: 41
  start-page: 82
  issue: 1
  year: 2012
  ident: 1085_CR34
  publication-title: Endocrine.
  doi: 10.1007/s12020-011-9509-7
– volume: 17
  start-page: 2937
  year: 2006
  ident: 1085_CR38
  publication-title: J Am Soc Nephrol.
  doi: 10.1681/ASN.2006040368
– volume: 34
  start-page: 975
  year: 2011
  ident: 1085_CR18
  publication-title: Diabetes Care.
  doi: 10.2337/dc10-1545
– volume: 40
  start-page: 221
  year: 2002
  ident: 1085_CR11
  publication-title: Am J Kidney Dis.
  doi: 10.1053/ajkd.2002.34487
– volume: 130
  start-page: 461
  year: 1999
  ident: 1085_CR25
  publication-title: Ann Intern Med.
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 357
  start-page: 1130
  issue: 4
  year: 2007
  ident: 1085_CR36
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1016/j.bbrc.2007.04.072
– volume: 293
  start-page: E1311
  year: 2007
  ident: 1085_CR28
  publication-title: Am J Physiol Endocrinol Metab.
  doi: 10.1152/ajpendo.00299.2007
– volume: 33
  start-page: 1536
  year: 2010
  ident: 1085_CR5
  publication-title: Diabetes Care.
  doi: 10.2337/dc09-1098
– volume: 27
  start-page: 1144
  issue: 10
  year: 2010
  ident: 1085_CR10
  publication-title: Diabet Med.
  doi: 10.1111/j.1464-5491.2010.03083.x
– volume: 37
  start-page: 532
  issue: 5
  year: 1988
  ident: 1085_CR27
  publication-title: Diabetes.
  doi: 10.2337/diab.37.5.532
– volume: 177
  start-page: 361
  year: 2007
  ident: 1085_CR8
  publication-title: CMAJ.
  doi: 10.1503/cmaj.061590
– volume: 115
  start-page: 610
  issue: 3
  year: 2005
  ident: 1085_CR35
  publication-title: J Clin Invest.
  doi: 10.1172/JCI23056
– volume: 38
  start-page: 1
  year: 2005
  ident: 1085_CR12
  publication-title: Clin Biochem.
  doi: 10.1016/j.clinbiochem.2004.09.025
– volume: 50
  start-page: 935
  year: 2013
  ident: 1085_CR32
  publication-title: Acta Diabetol.
  doi: 10.1007/s00592-013-0485-7
– volume: 295
  start-page: F1589
  year: 2008
  ident: 1085_CR3
  publication-title: Am J Physiol Renal Physiol.
  doi: 10.1152/ajprenal.00142.2008
– volume: 355
  start-page: 253
  year: 2000
  ident: 1085_CR23
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(99)12323-7
– volume: 36
  start-page: 656
  year: 2013
  ident: 1085_CR17
  publication-title: Diabetes Care.
  doi: 10.2337/dc12-0849
– volume: 44
  start-page: 288
  issue: 3
  year: 2006
  ident: 1085_CR30
  publication-title: Clin Chem Lab Med.
  doi: 10.1515/CCLM.2006.050
– volume: 289
  start-page: 3273
  year: 2003
  ident: 1085_CR6
  publication-title: JAMA.
  doi: 10.1001/jama.289.24.3273
– volume: 12
  start-page: 177
  year: 2005
  ident: 1085_CR2
  publication-title: Adv Chronic Kidney Dis.
  doi: 10.1053/j.ackd.2005.01.008
– volume: 37
  start-page: 226
  year: 2014
  ident: 1085_CR4
  publication-title: Diabetes Care.
  doi: 10.2337/dc13-0985
– volume: 26
  start-page: 258
  year: 2011
  ident: 1085_CR9
  publication-title: J Korean Med Sci.
  doi: 10.3346/jkms.2011.26.2.258
– ident: 1085_CR24
– volume: 285
  start-page: F9
  year: 2003
  ident: 1085_CR13
  publication-title: Am J Physiol Renal Physiol.
  doi: 10.1152/ajprenal.00008.2003
– reference: 16565256 - J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7
– reference: 17698825 - CMAJ. 2007 Aug 14;177(4):361-8
– reference: 12148093 - Am J Kidney Dis. 2002 Aug;40(2):221-6
– reference: 14514731 - J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43
– reference: 23939543 - Diabetes Care. 2014;37(1):226-34
– reference: 16519600 - Clin Chem Lab Med. 2006;44(3):288-91
– reference: 24250725 - Exp Ther Med. 2013 Dec;6(6):1482-1488
– reference: 20854382 - Diabet Med. 2010 Oct;27(10 ):1144-50
– reference: 15811456 - Lancet. 2005 Apr 2-8;365(9466):1231-8
– reference: 23093662 - Diabetes Care. 2013 Mar;36(3):656-61
– reference: 17711985 - Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1311-9
– reference: 23754672 - Acta Diabetol. 2013 Dec;50(6):935-42
– reference: 21779943 - Endocrine. 2012 Feb;41(1):82-8
– reference: 15492944 - Am J Kidney Dis. 2004 Nov;44(5):792-8
– reference: 23770456 - Clin Biochem. 2013 Aug;46(12):1128-30
– reference: 19212447 - Clin Transl Sci. 2008 Dec;1(3):200-8
– reference: 12824208 - JAMA. 2003 Jun 25;289(24):3273-7
– reference: 15822053 - Adv Chronic Kidney Dis. 2005 Apr;12(2):177-86
– reference: 21307379 - Diabetes Care. 2011 Apr;34(4):975-81
– reference: 23966807 - Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13
– reference: 23067652 - Am J Kidney Dis. 2012 Nov;60(5):850-86
– reference: 22950063 - Diabetes Metab J. 2012 Aug;36(4):307-13
– reference: 3360214 - Diabetes. 1988 May;37(5):532-9
– reference: 21286018 - J Korean Med Sci. 2011 Feb;26(2):258-63
– reference: 17462596 - Biochem Biophys Res Commun. 2007 Jun 15;357(4):1130-4
– reference: 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89
– reference: 12788784 - Am J Physiol Renal Physiol. 2003 Jul;285(1):F9-18
– reference: 20413518 - Diabetes Care. 2010 Jul;33(7):1536-43
– reference: 15607309 - Clin Biochem. 2005 Jan;38(1):1-8
– reference: 15148457 - Am J Nephrol. 2004 May-Jun;24(3):307-15
– reference: 24357215 - Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
– reference: 22015481 - Diabetes Res Clin Pract. 2012 Jan;95(1):105-9
– reference: 10075613 - Ann Intern Med. 1999 Mar 16;130(6):461-70
– reference: 19118149 - J Am Soc Nephrol. 2009 Mar;20(3):489-94
– reference: 10675071 - Lancet. 2000 Jan 22;355(9200):253-9
– reference: 18579704 - Am J Physiol Renal Physiol. 2008 Dec;295(6):F1589-600
– reference: 15711640 - J Clin Invest. 2005 Mar;115(3):610-21
SSID ssj0008959
Score 2.2816105
Snippet Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the...
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes...
Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 895
SubjectTerms Acute-Phase Proteins - urine
Adult
Albuminuria - urine
Biomarkers - urine
Creatinine - urine
Cystatin C - urine
Diabetic Nephropathies - urine
Female
Humans
Kidney Function Tests
Lipids - blood
Lipocalin-2
Lipocalins - urine
Male
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Original Article
Prediabetic State - urine
Proto-Oncogene Proteins - urine
Urology
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB60gngRbX1Uq0QQD8rivrKbnqSIpQjtyUJvSzabQKHu1j6E_ntn9tEqxV72stlsyEwmk5kv3wDcmyTgKqSsv9G25ROAMCbaSk_YSjtSC51TCvUHQW_ov4_4qAy4zUtYZWUTc0OdZIpi5M90VBEh0W-9TL8sqhpF2dWyhMY-HBB1GUG6wtH6wGWLdl4szfF818Jt0qmymsXVOYcT6JJ4OAW3vL_70pazuZUozfef7gkcl44j6xSSPoU9ndah0Unx0Py5Yg8sh3LmMfI6HPbLjHkD_EH2rSeMYupytmJ0254AObM5G6eMICBF8HWsWKqnVDIBPcLVGQy7bx-vPauslGApKkhgKekajbbHDwJJ0HzKzgruhopr4Rgl23YSJp6tBXoHPOHSlng0NSIWiUCLx6V3DrU0S_UlMONox_jtUCt0TXwTy1DFVJ3GBNxLUHhNsKt5ilRJI07VLCbRhgCZpjbCB7GP8shrwuP6k2nBobGrcaua_KhcTvNoI_wm3K1f40Kg7IZMdbbM26C74bYD3oSLQmjrv6FfhzrAsfOnSoq_Ov9vKFe7h3INR26hP6hGLagtZkt9gx7KIr7N1fAHN-_dlQ
  priority: 102
  providerName: ProQuest
Title Novel urinary biomarkers in pre-diabetic nephropathy
URI https://link.springer.com/article/10.1007/s10157-015-1085-3
https://www.ncbi.nlm.nih.gov/pubmed/25634253
https://www.proquest.com/docview/1721878550
https://www.proquest.com/docview/1722422965
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB5sC-JF1PqIj7KCeFACeW2yPVapimIRsVBPYbPZhUJNpbVC_70zedSKD_CSHLLZLDuT2W92Zr8BODFpyFVEUX-jHTugBMKEaCt94SjtSi10Til03wtv-sHtgA_Kc9zTKtu9CknmlnrpsJvLKU2SmDMFt_0aNDi57qjEfa-zML-inVdIc_3As3FtdKtQ5k9dfF2MviHMb9HRfNG52oD1Ei2yTiHeTVjR2RY0Oxl6yi9zdsry_M18Y3wLVu_LMHkTgt74XY8YbaTLyZzREXvKwplM2TBjlPdR7LgOFcv0K9VJQBg434b-Vffp8sYuyyPYiqoQ2Ep6RqPBCcJQUj4-hWQF9yLFtXCNkm0njVLf0QIhAU-5dCT6o0YkIhVo5rj0d6CejTO9B8y42jVBO9IK8UhgEhmphErSmJD7KUrMAqeap1iV3OFUwmIUf7Ie09TGeCHKUR77FpwtXnktiDP-anxYTX5c_kPTmJxTERHhmgXHi8eo_RTSkJkez_I2iDG8dsgt2C2EtvgagjnUAY6dn1dSXOr8t6Hs_6v1Aax5hTqhVh1C_W0y00eIUt6SFtSiQdSCRuf6-a6L94tu7-GxlevqB-5T3hs
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB50BfVFvF3PCOqDUuyVNvsg4sl67CKi4FtN0wQWtLvuerB_yt_oTI9VEX3zpS9N0zCZmcyVbwA2TBJwFVLW32jb8qmAMCbYSk_YSjtSC51BCjWaQf3WP7_jd0PwXt6FobLKUidmijppK4qR75KrIkKC39rvPFnUNYqyq2ULjZwtLnT_DV223t7ZMe7vpuuentwc1a2iq4ClCLzfUtI1GuXUDwJJZeyUyRTcDRXXwjFK1uwkTDxbCzxJecKlLdGNMyIWiUDtwKWH8w7DiO-hK1OBkcOT5tX1QPeLWtaezfF818KD2SnzqPllPYdTmSchfwpued9Pwh_m7Y_UbHbinU7CRGGqsoOct6ZgSKfTMHOQopv-2GdbLCsezaLy0zDaKHL0M-A326_6gVEUX3b7jO73UwlQt8daKaOikzzc21Is1R1q0oA2aH8Wbv-FinNQSdupXgBmHO0YvxZqhcaQb2IZqpj64ZiAewmySxXskk6RKoDLqX_GQ_QJuUykjfBBeKc88qqwPfikk6N2_DV4uSR-VAhwL_pktyqsD16j6FE-Raa6_ZKNQQPHrQW8CvP5pg3-hpYk8gDHyXfKXfwy-W9LWfx7KWswVr9pXEaXZ82LJRh3c15CllqGynP3Ra-gffQcrxZMyeD-v-XgA7kOGgk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JSwMxFH64gHgRtS51jaAelKGzZSY9iIha1GrxoNDbmMkkUKjT2rrQv-av871ZqiJ68zKXSTJD8r3kbfkewK5JAq5CivobbVs-JRDGRFvpCVtpR2qhM0qhm1Zwce9ftXl7At7LuzCUVlnuidlGnfQU-chrZKqIkOi3aqZIi7g9axz3nyyqIEWR1rKcRg6Rph69ofk2PLo8w7Xec93G-d3phVVUGLAUEflbSrpGo8z6QSAppZ2imoK7oeJaOEbJup2EiWdrgacqT7i0JZp0RsQiEbhTcOnhuJMwHWJfkrGwPTb2bFHPCrU5nu9aeEQ7ZUQ1v7bncEr4JA5QwS3v-5n4Q9H9EaTNzr7GPMwVSis7yVG2ABM6XYTKSYoG--OI7bMsjTTzzy_CzE0Rra-A3-q96i4jf74cjBjd9KdkoMGQdVJG6Se547ejWKr7VK4BtdHREtz_yxwuw1TaS_UqMONox_j1UCtUi3wTy1DFVBnHBNxLEDhVsMt5ilRBYU6VNLrRJ_kyTW2ED2I-5ZFXhYNxl37O3_FX441y8qNClIfRJ_CqsDN-jUJIkRWZ6t5L1gZVHbce8Cqs5Is2_hrqlIgBjoMflqv4ZfDffmXt71_ZhhlEf3R92Wquw6ybQwkRtQFTz4MXvYmK0nO8lSGSwcN_i8AHMwIc2Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+urinary+biomarkers+in+pre-diabetic+nephropathy&rft.jtitle=Clinical+and+experimental+nephrology&rft.au=Garg%2C+Vikas&rft.au=Kumar%2C+Manish&rft.au=Mahapatra%2C+Himansu+Sekhar&rft.au=Chitkara%2C+Anubhuti&rft.date=2015-10-01&rft.issn=1342-1751&rft.eissn=1437-7799&rft.volume=19&rft.issue=5&rft.spage=895&rft.epage=900&rft_id=info:doi/10.1007%2Fs10157-015-1085-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10157_015_1085_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1342-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1342-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1342-1751&client=summon